ENERGIZE THE FIGHT.
HOLIDAY SEASON
See how you can help support Kendall, Scarlett, and the thousands of other affected patients and families UMDF serves this holiday season.
Our Mito Champions
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Need to Connect with Us?
Call the Support Line: (888) 900-6486
Ask the Mito Doc – February 2023: Cardiac Disease and the Mitochondrial Patient
Ask the Mito Doc February 2023 Cardiac Disease and the Mitochondrial Patient Clinicians: Hilary Vernon, MD, PhD, Reid Thompson MD, Rebecca McClellan, MGC, CGC. From Johns Hopkins School of Medicine Watch the video: https://youtu.be/lTKIasetPJM Q: How does...
Reata Pharmaceuticals Announces FDA Approval of SKYCLARYS™ (Omaveloxolone) for Friedreich’s Ataxia. Learn What this Means for the Mito Community.
March 1, 2023 -- The United Mitochondrial Disease Foundation (UMDF) applauds the decision by the U.S. Food and Drug Administration (FDA) to approve a medication to treat Friedreich’s Ataxia (FA), making it the first disease associated with mitochondrial dysfunction to...
Research Update from 2015 UMDF Grant Recipient Sara Nowinski, PhD
In 2015, Sara Nowinski, PhD received a $70,000 grant award for her work “Characterizing the Function of the Atypical Mitochondrial Kinase ADCK3.” Dr. Nowinski’s work endeavored to improve the understanding of ADCK3 function in the synthesis of coenzyme Q and...